Skip to Content

Global Pharmatech Inc GBLP

Morningstar Rating
$0.35 +0.20 (133.33%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GBLP is trading at a 690% premium.
Price
$0.35
Fair Value
$5.76
Uncertainty
Extreme
1-Star Price
$1.84
5-Star Price
$4.23
Economic Moat
Thcx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GBLP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.15
Day Range
$0.350.35
52-Week Range
$0.120.35
Bid/Ask
$0.11 / $0.40
Market Cap
$8.26 Mil
Volume/Avg
750 / 875

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Global Pharmatech Inc through its subsdiaries, discovers, develops, manufactures and markets proprietary drugs developed based on Traditional Chinese Medicine (TCM) while utilizing modern facilities and R&D technologies. Geographically, majority of the business activities are carried out through People's Republic of China with sales distribution in China, Hong Kong, Singapore, Malaysia, Indonesia and USA.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
217
Website

Valuation

Metric
GBLP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
GBLP
Quick Ratio
1.50
Current Ratio
1.86
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
GBLP
Return on Assets (Normalized)
−16.24%
Return on Equity (Normalized)
−25.80%
Return on Invested Capital (Normalized)
−17.95%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
BrbqkgcwhQwsfln$79.0 Bil
Zoetis Inc Class A
ZTS
BrtdnnygwbHtdq$77.4 Bil
Haleon PLC ADR
HLN
ChzksttsQgt$37.7 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
JxjnjvtnsGrz$19.3 Bil
Viatris Inc
VTRS
KnqkzpvkcCpxq$12.0 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
XyfjnlxnNnqpm$12.0 Bil
Catalent Inc
CTLT
FdwzmyzqyYdtkxg$10.0 Bil
Perrigo Co PLC
PRGO
ZvmfkzhHslp$3.5 Bil
Prestige Consumer Healthcare Inc
PBH
VnzzhqfvgMvctnc$3.2 Bil
Curaleaf Holdings Inc
CURLF
DwlllsdlnHlncn$2.9 Bil

Sponsor Center